Publications

ROADSTER IDE Study Results

Results of the ROADSTER Multicenter Trial of Transcarotid Stenting with Dynamic Flow Reversal.

Kwolek CJ, Jaff MR, Leal JI, Hopkins LN, Shah RM, Hanover TM, Macdonald S, Cambria RP.
J Vasc Surg. 2015 Nov;62(5):1227-34.

TCAR Procedure Publications

Technical aspects of transcarotid artery revascularization using the ENROUTE transcarotid neuroprotection and stent system

Malas MB, Leal J, Kashyap V, Cambria RP, Kwolek CJ, Criado E.
J Vasc Surg. 2017 Mar;65(3):916-920.

Transcarotid Artery Revascularization With Flow Reversal*

Alpaslan A, Wintermark M, Pintér L, Macdonald S, Ruedy R, Kolvenbach R.
J Endovasc Ther. 2017 Apr;24(2):265-270.

Transcervical Carotid Stenting With Dynamic Flow Reversal Demonstrates Embolization Rates Comparable to Carotid Endarterectomy*

Plessers M, Van Herzeele I, Hemelsoet D, Patel N, Chung EM, Vingerhoets G, Vermassen F.
J Endovasc Ther. 2016 Apr;23(2):249-54.

New technologies for CAS that might overcome the burden of microembolization.*

Yamada R1, Guimaraes M, Adams J, Schönholz C.
J Cardiovasc Surg (Torino). 2015 Dec;56(6):859-65.

Safety and feasibility of a novel transcervical access neuroprotection system for carotid artery stenting in the PROOF Study.*

Pinter L, Ribo M, Loh C, Lane B, Roberts T, Chou TM, Kolvenbach RR.
J Vasc Surg. 2011 Nov:54(5):1317-23.

First clinical use of a novel neurovascular access and neuroprotection system demonstrates complete absence of emboli by transcranial Doppler during carotid artery stenting.*

Pinter L, Ribo M, Roberts T, Chou TM, Kolvenbach RR.
J Cardiovasc Surg (Torino). 2011 Dec:52(6):853-7.

Articles

Transcervical carotid stenting with dynamic flow reversal demonstrates embolisation rates comparable to carotid endarterectomy*

Maarten Plessers, MSc
Vascular News, April 2016

Is CAS a Reasonable Alternative to CEA?

Wesley Moore, MD
Vascular Specialist April 2016 page 2

Avoiding the Aortic Arch and Using Flow Reversal: Carotid Artery Stenting with the Silk Road System to Reduce Stroke.

Richard Cambria, MD. Cath Lab Digest. 2014. April: 22(4):12,14

An Overview of the ROADSTER Trial.

Christopher J. Kwolek, MD, and Richard M. Ruedy. Endovascular Today. 2013. Sept.

* The ENROUTE NPS and Stent Systems are approved for use in the EU in patients at standard risk for complications from CEA. These indications have not been evaluated by the US FDA.
The links on this page take you away from the Silk Road Medical website. These websites are not operated by Silk Road Medical. Silk Road Medical does not control the content of these websites.
  • ©2017 Silk Road Medical

  • 735 North Pastoria Avenue,
    Sunnyvale, CA 94085

    phone: 855.410.TCAR (8227)
    local phone: 408.720.9002
    fax: 408.720.9013